Loading stock…

Bank Albilad (1140) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

1140Bank Albilad

Revenue FY25$1.6B

GROWTH RATING↗

——

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+9%–

Revenue, next 1Yna–

Revenue, next 3Y, CAGR+10%–

Revenue, next 5Y, CAGR+6%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+11%7

EPS growth, FY27E-3%3

EPS growth, FY28E+9%6

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue is set to grow 10%/yr over the next 3 years, in line with the market.5/10

Revenue grew 9%/yr over the last 3 years and is set to keep growing around 10%/yr.

Over five years revenue is set to grow 6%/yr, about average versus companies worldwide.5/10

Earnings are set to grow in step with sales (EPS about 9%/yr vs revenue 10%/yr). One year dips: EPS falls 3% in year 2.

WEAKNESSES

Growth is the weak spot here, trailing 100% of companies worldwide.

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

1140Bank Albilad

Total return Current205%

Price return Current181%

MOMENTUM RATING↗

WEAK27 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%3

3-month return-1%6

YTD return-2%4

MID & LONG-TERM▾SCORE

% of 52-week high80%5

1-year return-16%3

3-year return-5%3

5-year return+21%4

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

It's down 16% over the past year, now 20% below its 52-week high. That is a touch behind the market.

Returns sit at the market level over three months (-1%) and so far this year (-2%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-4.7% over three years and +21% over five), behind 60% of the market.

The stock is underperforming over the past month (-9%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Bank Albilad. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

1140Bank Albilad

Revenue FY25$1.6B

GROWTH RATING↗

——

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+9%–

Revenue, next 1Yna–

Revenue, next 3Y, CAGR+10%–

Revenue, next 5Y, CAGR+6%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+11%7

EPS growth, FY27E-3%3

EPS growth, FY28E+9%6

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue is set to grow 10%/yr over the next 3 years, in line with the market.5/10

Revenue grew 9%/yr over the last 3 years and is set to keep growing around 10%/yr.

Over five years revenue is set to grow 6%/yr, about average versus companies worldwide.5/10

Earnings are set to grow in step with sales (EPS about 9%/yr vs revenue 10%/yr). One year dips: EPS falls 3% in year 2.

WEAKNESSES

Growth is the weak spot here, trailing 100% of companies worldwide.

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

1140Bank Albilad

Total return Current205%

Price return Current181%

MOMENTUM RATING↗

WEAK27 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%3

3-month return-1%6

YTD return-2%4

MID & LONG-TERM▾SCORE

% of 52-week high80%5

1-year return-16%3

3-year return-5%3

5-year return+21%4

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

It's down 16% over the past year, now 20% below its 52-week high. That is a touch behind the market.

Returns sit at the market level over three months (-1%) and so far this year (-2%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-4.7% over three years and +21% over five), behind 60% of the market.

The stock is underperforming over the past month (-9%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Bank Albilad. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Bank Albilad

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Bank Albilad. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Bank Albilad. Get the full investment case.

Premium